Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy
Subhi J. Al’Aref(Cornell University), Cristina Presicci(University of Parma), Silvia Pradella(Azienda Ospedaliero-Universitaria Careggi), Marta Focardi(University of Siena), Stefano Censi(Maria Cecilia Hospital), Francesca Marzo(Ospedale Infermi di Rimini), Gabriella Di Giovine(University of Foggia), Martina Perazzolo Marra(Azienda Ospedale - Università Padova), Monica Dobrovie(KU Leuven), Davide Margonato(Fondazione Lanza), Claudio Moro(University of Lausanne), Matteo Gravina(University of Foggia), Gloria Cicala(Ospedale di Parma), Mauro Roma(Istituto di Radioastronomia di Bologna), Marco Guglielmo(Utrecht University), Valentina Lorenzoni(Fondazione Toscana Gabriele Monasterio), Silvia Pica(National Institutes of Health), Anna Giulia Pavon(Ente Ospedaliero Cantonale), Abdallah Malkawi(University of Arkansas for Medical Sciences), Mauro Pepi(Centro Cardiologico Monzino), Nazario Carrabba(Azienda Ospedaliero-Universitaria Careggi), Giovanni Donato Aquaro(Fondazione Toscana Gabriele Monasterio), Patrizia Pedrotti(Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda), Lohendran Baskaran(Duke-NUS Medical School), Edoardo Conte(University of Milan), Pier Giorgio Masci, Andrea Barison(Scuola Superiore Sant'Anna), Ambra Masi(MACOM (United States)), Samuela Carigi(University of Foggia), Massimo Lombardi(Fondazione Toscana Gabriele Monasterio), Alberto Nese(Ca' Foncello Hospital), Raffaele Abete(University of Foggia), Ahmad Masri(Oregon Health & Science University), Chiara Lanzillo(ASL Roma), Nicola Gaibazzi(University of Parma), Jan Bogaert(KU Leuven), Ahmed Altibi(Oregon Health & Science University), Giovanni Camastra(Nini Hospital), Munthir Mansour(University of Arkansas for Medical Sciences), Carlo N. De Cecco(Emory Healthcare), Hind Rahmouni(Oregon Health & Science University), Manuel De Lazzari(Azienda Ospedale - Università Padova), Jordi Lozano-Torres(Universitat Autònoma de Barcelona), Saima Mushtaq(Centro Cardiologico Monzino), Grazia Casavecchia(University of Foggia), Chiara Martini(University of Parma), Annalaura Gismondi(University of Siena), Daniele Andreini(Centro Cardiologico Monzino), Riccardo Memeo, Alessandro Palumbo(University of Parma)
Cited by 17
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
|Journal of the American Society of Echocardiography|2011|1.1k
Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy
|Circulation|2014|1k
Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
|European Heart Journal|2011|764
State of the Art: Iterative CT Reconstruction Techniques
|Radiology|2015|704